Search research articles
Contact Us
Filters
Showing results (61-70 of 86) with videos related to
Page
of 9
Sort By:
Journal of Medicinal Chemistry
|
March 23, 2019
Discovery of Novel Janus Kinase (JAK) and Histone Deacetylase (HDAC) Dual Inhibitors for the Treatment of Hematological Malignancies
Xuewu Liang, Jie Zang, Xiaoyang Li, et al.
Cancer Letters
|
June 13, 2017
Tanshinone IIA inhibits β-catenin/VEGF-mediated angiogenesis by targeting TGF-β1 in normoxic and HIF-1α in hypoxic microenvironments in human colorectal cancer
Hua Sui, Jihui Zhao, Lihong Zhou, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
April 22, 2026
Discovery of a Potent Fluorescence Polarization Probe for Identifying USP1 Allosteric Inhibitors
Jiawei Cheng, Peipei Wang, Pengfei Wang, et al.
Bioorganic & Medicinal Chemistry
|
September 3, 2013
Synthesis and biological evaluation of 2-amino-5-aryl-3-benzylthiopyridine scaffold based potent c-Met inhibitors
Dengyou Zhang, Xiaowei Zhang, Jing Ai, et al.
Journal of Medicinal Chemistry
|
July 18, 2017
Design, Synthesis, and Pharmacological Evaluation of Novel Multisubstituted Pyridin-3-amine Derivatives as Multitargeted Protein Kinase Inhibitors for the Treatment of Non-Small Cell Lung Cancer
Wei Zhu, Hui Chen, Yulan Wang, et al.
ACS Medicinal Chemistry Letters
|
March 19, 2021
Discovery of 5-Benzylidene-2-phenyl-1,3-dioxane-4,6-diones as Highly Potent and Selective SIRT1 Inhibitors
Chunpu Li, Sha-Sha Hu, Lisheng Yang, et al.
Chemical Communications (Cambridge, England)
|
December 22, 2022
Synthesis of maleimide-braced peptide macrocycles and their potential anti-SARS-CoV-2 mechanisms
Jian Li, Jina Sun, Xianglei Zhang, et al.
Journal of Medicinal Chemistry
|
February 24, 2022
Structure-Activity Relationship Study of Indolin-5-yl-cyclopropanamine Derivatives as Selective Lysine Specific Demethylase 1 (LSD1) Inhibitors
Chunpu Li, Mingbo Su, Wei Zhu, et al.
Journal of Medicinal Chemistry
|
February 15, 2021
Discovery of Novel Pyrrolo[2,3-<i>d</i>]pyrimidine-based Derivatives as Potent JAK/HDAC Dual Inhibitors for the Treatment of Refractory Solid Tumors
Xuewu Liang, Shuai Tang, Xuyi Liu, et al.
Journal of Medicinal Chemistry
|
September 2, 2022
Discovery of Novel Imidazo[4,5-<i>c</i>]quinoline Derivatives to Treat Inflammatory Bowel Disease (IBD) by Inhibiting Multiple Proinflammatory Signaling Pathways and Restoring Intestinal Homeostasis
Xuewu Liang, Yongle Xie, Xuyi Liu, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 86) with videos related to
Sort By:
Page
of 9
Journal of Medicinal Chemistry
|
March 23, 2019
Discovery of Novel Janus Kinase (JAK) and Histone Deacetylase (HDAC) Dual Inhibitors for the Treatment of Hematological Malignancies
Xuewu Liang, Jie Zang, Xiaoyang Li, et al.
Cancer Letters
|
June 13, 2017
Tanshinone IIA inhibits β-catenin/VEGF-mediated angiogenesis by targeting TGF-β1 in normoxic and HIF-1α in hypoxic microenvironments in human colorectal cancer
Hua Sui, Jihui Zhao, Lihong Zhou, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
April 22, 2026
Discovery of a Potent Fluorescence Polarization Probe for Identifying USP1 Allosteric Inhibitors
Jiawei Cheng, Peipei Wang, Pengfei Wang, et al.
Bioorganic & Medicinal Chemistry
|
September 3, 2013
Synthesis and biological evaluation of 2-amino-5-aryl-3-benzylthiopyridine scaffold based potent c-Met inhibitors
Dengyou Zhang, Xiaowei Zhang, Jing Ai, et al.
Journal of Medicinal Chemistry
|
July 18, 2017
Design, Synthesis, and Pharmacological Evaluation of Novel Multisubstituted Pyridin-3-amine Derivatives as Multitargeted Protein Kinase Inhibitors for the Treatment of Non-Small Cell Lung Cancer
Wei Zhu, Hui Chen, Yulan Wang, et al.
ACS Medicinal Chemistry Letters
|
March 19, 2021
Discovery of 5-Benzylidene-2-phenyl-1,3-dioxane-4,6-diones as Highly Potent and Selective SIRT1 Inhibitors
Chunpu Li, Sha-Sha Hu, Lisheng Yang, et al.
Chemical Communications (Cambridge, England)
|
December 22, 2022
Synthesis of maleimide-braced peptide macrocycles and their potential anti-SARS-CoV-2 mechanisms
Jian Li, Jina Sun, Xianglei Zhang, et al.
Journal of Medicinal Chemistry
|
February 24, 2022
Structure-Activity Relationship Study of Indolin-5-yl-cyclopropanamine Derivatives as Selective Lysine Specific Demethylase 1 (LSD1) Inhibitors
Chunpu Li, Mingbo Su, Wei Zhu, et al.
Journal of Medicinal Chemistry
|
February 15, 2021
Discovery of Novel Pyrrolo[2,3-<i>d</i>]pyrimidine-based Derivatives as Potent JAK/HDAC Dual Inhibitors for the Treatment of Refractory Solid Tumors
Xuewu Liang, Shuai Tang, Xuyi Liu, et al.
Journal of Medicinal Chemistry
|
September 2, 2022
Discovery of Novel Imidazo[4,5-<i>c</i>]quinoline Derivatives to Treat Inflammatory Bowel Disease (IBD) by Inhibiting Multiple Proinflammatory Signaling Pathways and Restoring Intestinal Homeostasis
Xuewu Liang, Yongle Xie, Xuyi Liu, et al.
Page
of 9